Quarterly report pursuant to Section 13 or 15(d)

Statements of Changes in Stockholders' Deficit (Unaudited)

v3.19.1
Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-In Capital [Member]
Accumulated Deficit [Member]
Total
Balance at Dec. 31, 2017 $ 368 $ 1,711,197 $ (11,460,989) $ (9,749,424)
Balance, shares at Dec. 31, 2017 3,679,500      
Stock-based compensation expense 28,054 28,054
Stock-based compensation expense, shares      
Issuance of warrants to third parties for capital raise 304,395 304,395
Net income loss (1,412,686) (1,412,686)
Balance at Mar. 31, 2018 $ 368 2,043,646 (12,873,675) (10,829,661)
Balance, shares at Mar. 31, 2018 3,679,500      
Balance at Dec. 31, 2018 $ 987 20,152,107 (39,112,401) (18,959,307)
Balance, shares at Dec. 31, 2018 9,870,873      
Stock-based compensation expense 105,642 105,642
Stock-based compensation expense, shares      
Issuance of warrants to third parties for capital raise       594,293
Issuance of common stock upon exercise of Series A Warrants, net of cost $ 42 2,172,638 2,172,680
Issuance of common stock upon exercise of Series A Warrants, net of cost, shares 424,116      
Issuance of common stock as inducement to exercise Series A Warrants $ 51 (51)
Issuance of common stock as inducement to exercise Series A Warrants, shares 508,940      
Issuance of common stock upon exercise of Placement Agent Warrants 16,818 16,818
Issuance of common stock upon exercise of Placement Agent Warrants, shares 4,004      
Issuance of common stock upon exercise of Series B warrants $ 363 5,635,406 5,635,769
Issuance of common stock upon exercise of Series B warrants, shares 3,629,045      
Net income loss 500,213 500,213
Balance at Mar. 31, 2019 $ 1,443 $ 28,082,560 $ (38,612,188) $ (10,528,185)
Balance, shares at Mar. 31, 2019 14,436,978